Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2003
08/07/2003WO2003006981A3 Measuring cell for recording the electrical potential of a sample
08/07/2003WO2003000271A8 System and method for the large scale labeling of compounds with radiohalogens
08/07/2003WO2002100770A3 Wafer assembly and a method for producing a wafer assembly
08/07/2003WO2002098364A3 Magnetic-nanoparticle conjugates and methods of use
08/07/2003WO2002084285A3 Gradient resolved hybridisation platform
08/07/2003WO2002084262A3 Processes for evaluating agricultural and/or food materials; applications; and, products
08/07/2003WO2002084261A3 Optically similar reference samples and related methods for multivariate calibration models used in optical spectroscopy
08/07/2003WO2002079763A3 Tissue-based standoff biosensors for detecting chemical or biological warfare agents
08/07/2003WO2002079268A3 Tuning the properties of conjugated polyelectrolytes and application in a biosensor platform
08/07/2003WO2002072627A3 Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination
08/07/2003WO2002061114A9 Water-soluble, fluorescent and mobile peptide substrates
08/07/2003WO2002059611A3 Diagnosis and treatment of cancer using mammalian pellino polypeptides and polynucleotides
08/07/2003WO2002059363A3 Method for detecting of prions in a sample
08/07/2003WO2002057783A3 Method of screening for gpr40 ligands
08/07/2003WO2002057457A3 Human proteins 55562 and 21617, and methods of use thereof
08/07/2003WO2002050523A3 Inspection and disposition of mill rolls
08/07/2003WO2002050288A9 Neocentromere-based mini-chromosomes or artificial chromosomes
08/07/2003WO2002046386A3 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
08/07/2003WO2002033422A3 Methods for detecting retinopathy of prematurity
08/07/2003WO2002033404A3 Integrated wine quality sensor
08/07/2003WO2002033119A3 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
08/07/2003WO2002027329A3 Biomarkers of transitional cell carcinoma of the bladder
08/07/2003WO2002027321A3 Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients
08/07/2003WO2002024943A3 Method of identifying osteoregenerative agents using differential gene expression
08/07/2003WO2002020848A3 Gene and sequence variation associated with cancer
08/07/2003WO2002018608A9 Methods for enhancing the efficacy of cancer therapy
08/07/2003WO2002014873A3 Methods and agents for detecting diseases that are associated with a disorder of the no metabolism
08/07/2003WO2002008381A3 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
08/07/2003WO2002004681A3 Method of detection by enhancement of silver staining
08/07/2003WO2002004678A3 Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders
08/07/2003WO2002002593A3 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
08/07/2003WO2001098524A3 Protein-protein interactions
08/07/2003WO2001092578A3 Reagents and methods for identifying and modulating expression of genes regulated by retinoids
08/07/2003WO2001090417A3 Materials and methods for detection of nucleic acids
08/07/2003WO2001053792A3 A system for detecting substances
08/07/2003WO1999042489A3 System and method for determining molecular weight and intrinsic viscosity of a polymeric distribution using gel permeation chromatography
08/07/2003US20030150010 Comprises nucleotide sequences coding thioredoxin h protein for improving baking quality of cereal flour; neutralization of venomons; food processing
08/07/2003US20030150005 Rodent model comprising genes coding hypoxia inducible factor (HIF) for detection of hypoxic tissue
08/07/2003US20030150000 Biological models capable of exhibiting secondary disease manifestations and useful for developing therapeutic drugs, diagnostic products and therapeutic or diagnostic procedures, methods of using same, and cells, tissues and organs derived therefrom
08/07/2003US20030149999 Nonhuman animal model non-responsive to mycoplasma-origin lipoprotein/lipopeptide
08/07/2003US20030149998 Nucleotide sequences coding orphan receptors/membrane proteins OM-10 and UP-11 for detecting modulators of inflammation, nervous system activity and infection; antitumor/antiinflammatory agents; gene expression inhibition
08/07/2003US20030149997 Using animal model to detect genotypic and/or phenotyic markers for aneurysms and age related macular degeneration(AMD); drug screening; immunoassays
08/07/2003US20030149995 Compound screening methods
08/07/2003US20030149994 Promoter for detecting transcription factors associated with controlling expression of nerve growth factor in cells
08/07/2003US20030149544 Spectral assessment of fruit
08/07/2003US20030149534 Gene associated with cancer
08/07/2003US20030149531 Serpentine transmembrane antigens expressed in human cancers and uses thereof
08/07/2003US20030149421 Method and apparatus for influencing the transport of blood carotenoids into intraductal breast fluid
08/07/2003US20030149375 Body fat determining device
08/07/2003US20030149372 Personal alarm device
08/07/2003US20030149353 Measurement of patient data requiring operator and patient identification
08/07/2003US20030149348 Micro optical sensor device
08/07/2003US20030149287 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds
08/07/2003US20030149259 Comprises oligonucleotide for high speed detection of microorganismal infection; veterinary medicine
08/07/2003US20030149258 Multiplex PCR primer set for human HNF-1alpha gene amplification
08/07/2003US20030149248 Using mathematical models to evaluate and monitor animal response to drug; side effect reduction; drug screening and delivery
08/07/2003US20030149247 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
08/07/2003US20030149246 Macromolecular conjugates and processes for preparing the same
08/07/2003US20030149242 Novel polypeptide
08/07/2003US20030149237 G-protein coupled receptor for treatment and prevention of eating, cancer, autoimmune, vision and nervous sytem disorders; antiinflammatory agents
08/07/2003US20030149113 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
08/07/2003US20030148990 Administering a therapeutically effective amount of an epidermal growth factor receptor (EGF-R) antagonist for therapy of hypersecretion of mucus in lungs
08/07/2003US20030148947 MIP as a research tool for identification, characterization and purification of molecules involved in cellular transport and osmotic regulation; agonists/antagonists; vision defects; anitinflammatory agents; nervous system and kidney disorders
08/07/2003US20030148944 Triple polypeptide complexes
08/07/2003US20030148930 Human zona pellucida proteins and methods of their use in diagnoising male infertility
08/07/2003US20030148921 Thrombin receptors; G-protein coupled transmembrane domain receptors; fusion protein kits
08/07/2003US20030148920 For inhibiting tumor-induced angiogenesis; antiischemic agents
08/07/2003US20030148577 Controlled alignment of catalytically grown nanostructures in a large-scale synthesis process
08/07/2003US20030148544 Methods of preparing multicolor quantum dot tagged beads and conjugates thereof
08/07/2003US20030148543 Method for conducting receptor-ligand association reaction
08/07/2003US20030148542 Kit and method for determining a plurality of analytes
08/07/2003US20030148541 Assay for measuring holo-transcobalamin and folate
08/07/2003US20030148540 Process for reducing ligand leakage from affinity chromatography matrices
08/07/2003US20030148534 Comprise thin film on a transparent substrate, a waveguide, an optical fiber or an electrode for monitoring ozone concentrations in hospitals and industry
08/07/2003US20030148532 Fluorescent detection of proteins in polyacrylamide gels
08/07/2003US20030148530 Point-of-care in-vitro blood analysis system
08/07/2003US20030148529 Utilization of invertebrate learning for flexible and sensitive monitoring and identification of chemicals
08/07/2003US20030148516 Medium containing flt3 ligand for culturing hematophoietic cells
08/07/2003US20030148514 Human embryonic germ cell line and methods of use
08/07/2003US20030148504 Comprises mechanically interlocked, replaceable microplates for amplification of nucleotide sequences
08/07/2003US20030148502 Comprises flow cell container for synthesizing immobilized oligomer probes
08/07/2003US20030148465 Comprises membrane protein for diagnosis and treatment of atherosclerosis, viral and inflammatory diseases
08/07/2003US20030148458 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/07/2003US20030148457 Monkey and canine melanin concentrating hormone receptors
08/07/2003US20030148451 Endothelial differntiation gene 6-like g protein coupled receptor
08/07/2003US20030148446 Acute neuronal induced calcium binding protein type 1 ligand
08/07/2003US20030148444 Sodium-independent small neutral amino acid transporters transporting L- and D-amino acids and genes thereof
08/07/2003US20030148443 Epoxide hydrolases, nucleic acids encoding them and methods of making and using them
08/07/2003US20030148439 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148438 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148437 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148436 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148435 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148434 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148433 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148432 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148431 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148430 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148428 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 ... 3937